ABOUT LUMEN BIOMEDICAL
Company Background
Our Mission: Enhancing Endovascular Procedures for Improved Clinical Outcomes.
Since being founded in July 2003, Lumen Biomedical’s primary goal has been to create unique interventional devices that outperform existing technologies and can be used in virtually any anatomical area. With this goal in mind, our experienced team of professionals has dedicated its efforts to developing and commercializing products for embolic protection and thrombus removal throughout the body.
News
Press releases and articles about Lumen Biomedical.
May 18, 2009
Volcano Announces Worldwide Exclusive Distribution Agreement With Lumen Biomedical for Xtract(TM) Thrombus Aspiration Catheter
Learn More
January 29, 2009
Invatec Announces Worldwide Distribution Agreement with Lumen Biomedical
Learn More
November 19, 2008
FDA Approves Lumen Biomedical’s FiberNet Embolic Protection System for Carotid Artery Stenting
Learn More
October 22, 2008
Lumen Biomedical Receives FDA Clearance of Embolectomy System for Treatment of Peripheral Artery Disease
Learn More
October 16, 2008
FiberNet EPS Clinical Trial Results
Learn More
October 3, 2008
Lumen Presence at TCT Conference
Learn More
January 1, 2008
Fibernet® Embolic Protection System, Exploring the Differences. Featured Technology, Endovascular Today
Learn More
